期刊文献+

地塞米松衍生物的合成及其抗肿瘤活性研究 被引量:4

Synthesis and anti-tumor actirities of dexamethasone derivative
下载PDF
导出
摘要 A new dexamethasone derivative of 9-fluoro-16α-methyl-11,17-dihydroxy-3-oxo-1,4-androsladiene-17β-carboxylic acid from dexamethasone is synthesized by oxidization with periodic acid. The physicochemical property of the new derivative is identified with routine methods. Its structure is characterized by 1H NMR,13C NMR and ESI-MS spectra. The effect of the new derivative on K562 cell proliferation was detected by MTT, as well as the cell cycle by flow cytometry.The result show that the dexamethasone derivative had anti-tumor activities of K562 cell proliferation inhibition and cell cycle arresting from G0/G1 to S phase. A new dexamethasone derivative of 9 - fluoro - 16α - methyl - 11,17 - dihydroxy - 3 - oxo - 1,4 - androsladiene - 17β - carboxylic acid from dexamethasone is synthesized by oxidization with periodic acid. The physicochemical property of the new derivative is identified with routine methods. Its structure is characterized by ^1 H NMR,^13C NMR and ESI - MS spectra. The effect of the new derivative on K562 cell proliferation was detected by MTT, as well as the cell cycle by flow cytometry. The result show that the dexamethasone derivative had anti - tumor activities of K562 cell proliferation inhibition and cell cycle arresting from G0/ G1 to S phase.
出处 《化学研究与应用》 CAS CSCD 北大核心 2008年第3期341-344,共4页 Chemical Research and Application
基金 国家自然科学基金(30300449)资助项目 国家中医药管理局(02-03ZP52)资助项目
关键词 地塞米松衍生物 合成 抗肿瘤活性 dexamethasone derivative synthesis anti - tumor activity
  • 相关文献

参考文献3

  • 1Zhang XP, Zhang L, Wang Y, et al. Study of the protective effects of dexamethasone on multiple organ injury in rats with severe acute pancreatitis [ J ]. JOP, 2007,8(4) :400 -412.
  • 2史剑慧,许小平,张宗梁,张劲松,葛均波,程文英.核因子-κB活化抑制增强高三尖杉酯碱诱导白血病细胞凋亡[J].中华内科杂志,2003,42(5):292-295. 被引量:11
  • 3Ozaki S, Tanaka O, Fujii S, et al. Therapy with bortezomib plus dexamethasone induces osteoblast activation in responsive patients with multiple myeloma [ J ]. Int. J. Hematol. ,2007,86 (2) : 180 - 185

二级参考文献2

共引文献10

同被引文献39

  • 1肖志坚,郝玉书.急性白血病治疗现况与未来[J].白血病.淋巴瘤,2006,15(1):78-80. 被引量:14
  • 2Roy L, Guilhot J, Krahnke T, et al. Survival advantage from imatinib compared with the combination interferon-alpha plus cytarabine in chronic-phase chronic myelogenous leukemia: historicalcomparison between two phase 3 trials [J]. Blood, 2006,108(5) : 1478-1484.
  • 3Gone ME, Mohmnmed M, Ellwood K, et al. Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification [J]. Science, 2001,293 (5531) : 876-880.
  • 4White DL, Saunders VA, Dang P, et al. OCT-l-mediated influx is a key determinant of the intracellular uptake of imatinib but not nilotinib (AMN 107) : reduced OCT- 1 activity is the cause of low in vitro sensitivity to imatinih [J]. Blood, 2006,108 ( 2 ) : 697-704.
  • 5Kim SJ, Kim J, Cho Y, et al. Combination chemotherapy with bortezomib, cyclophosphamide and dexamethasone may be effective for plasma cell leukemia [J]. Jpn J Clin Oncol, 2007,37(5 ) : 382-384.
  • 6Ozaki S, Tanaka O, Fujii S, et al. Therapy with bortezomib plus dexamethasone induces osteoblast activation in responsive patients with multiple myeloma [J]. Int J Hematol, 2007,86 (2) : 180-185.
  • 7Fields S, Song O. A novel genetic system to detect proteinprotein interactions [J]. Nature, 1989,340(6230) :245-246.
  • 8Sengupta DJ, Zhang B, Kraemer B, et al. A three-hybrid system to detect RNA-protein interactions in vivo [J]. Proc Natl Acad Sci USA, 1996,93(16):8496-8501.
  • 9Licitra EJ, Liu JO. A three-hybrid system for detecting small ligand-protein receptor interactions [J]. Proc Natl Acad Sci U S A, 1996,93(23):12817-12821.
  • 10Chen L, Yun SW, Seto J, et al. The fragile X mental retardation protein binds and regulates a novel class of mRNAs containing U rich target sequences [J]. Neurescience, 2003, 120(4) : 1005-1017.

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部